Orbimed-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
107
Total Value
4035711615
Accession Number
0001172661-25-002355
Form Type
13F-HR
Manager Name
Orbimed-Advisors
Data Enrichment
92% identified
98 identified9 unidentified

Holdings

107 positions • $4.0B total value
Manager:
Search and click to pin securities to the top
Page 5 of 6
Bicara Therapeutics Inc.
Shares:298.3K
Value:$3.9M
% of Portfolio:0.1% ($3.9M/$4.0B)
Q32 Bio Inc.
Shares:2.3M
Value:$3.7M
% of Portfolio:0.1% ($3.7M/$4.0B)
BioAge Labs, Inc.
Shares:922.0K
Value:$3.5M
% of Portfolio:0.1% ($3.5M/$4.0B)
Repare Therapeutics Inc.
Shares:3.3M
Value:$3.3M
% of Portfolio:0.1% ($3.3M/$4.0B)
Structure Therapeutics Inc.
Shares:150.0K
Value:$2.6M
% of Portfolio:0.1% ($2.6M/$4.0B)
Passage BIO, Inc.
Shares:7.0M
Value:$2.5M
% of Portfolio:0.1% ($2.5M/$4.0B)
INSMED Inc
Shares:28.7K
Value:$2.2M
% of Portfolio:0.1% ($2.2M/$4.0B)
Ceribell, Inc.
Shares:112.5K
Value:$2.2M
% of Portfolio:0.1% ($2.2M/$4.0B)
Instil Bio, Inc.
Shares:116.8K
Value:$2.0M
% of Portfolio:0.1% ($2.0M/$4.0B)
16385C104
Shares:1.7M
Value:$1.9M
% of Portfolio:0.0% ($1.9M/$4.0B)
Cardiff Oncology, Inc.
Shares:573.9K
Value:$1.8M
% of Portfolio:0.0% ($1.8M/$4.0B)
X4 Pharmaceuticals, Inc
Shares:6.8M
Value:$1.6M
% of Portfolio:0.0% ($1.6M/$4.0B)
Nkarta, Inc.
Shares:821.4K
Value:$1.5M
% of Portfolio:0.0% ($1.5M/$4.0B)
Traws Pharma, Inc.
Shares:605.5K
Value:$1.4M
% of Portfolio:0.0% ($1.4M/$4.0B)
FATE THERAPEUTICS INC
Shares:1.7M
Value:$1.3M
% of Portfolio:0.0% ($1.3M/$4.0B)
Turnstone Biologics Corp.
Shares:3.1M
Value:$1.3M
% of Portfolio:0.0% ($1.3M/$4.0B)
Amylyx Pharmaceuticals, Inc.
Shares:348.0K
Value:$1.2M
% of Portfolio:0.0% ($1.2M/$4.0B)
BiomX Inc.
Shares:1.8M
Value:$993.5K
% of Portfolio:0.0% ($993.5K/$4.0B)
Kezar Life Sciences, Inc.
Shares:192.7K
Value:$940.4K
% of Portfolio:0.0% ($940.4K/$4.0B)
Tango Therapeutics, Inc.
Shares:550.0K
Value:$753.5K
% of Portfolio:0.0% ($753.5K/$4.0B)